DCGO Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeValuation
- Forward P/E
- 60.24
- PEG ratio
- —
- P/B
- 0.46
- P/S (TTM)
- 0.21
- EV/EBITDA
- 5.57
Profitability & growth
- ROE (TTM)
- -89.0%
- Operating margin
- -43.3%
- Revenue growth YoY
- -38.0%
- Dividend yield
- —
- Beta
- 1.02
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
50 articles · sorted by dateVia 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About DocGo Inc
Company profileDocGo Inc. is a forward-thinking mobile healthcare service provider that transforms patient access through its cutting-edge logistics and telehealth platform. Focusing on urgent care, diagnostic testing, and health screenings, the company not only improves patient experiences but also optimizes healthcare delivery across various settings. With its robust technological advancements and dedication to expanding healthcare access, DocGo stands out as a compelling investment opportunity in the fast-growing healthtech landscape, appealing to institutional investors seeking growth potential.
Classification
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 685 THIRD AVENUE, NEW YORK, NY
- Fiscal year end
- December
- Latest quarter
- Dec 31, 2025
Educational content · Not investment advice or recommendations
We're educators, not advisors. Your decisions are your own. Disclaimer
I'm your AI thinking companion for the markets — I can help you explore and learn, but I'm not a financial advisor. Everything here is educational. Disclaimer